placeholder image
R. L. Fisher All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study. 
    Journal of Infectious Diseases. 2001
    • Contact
    full name
  • R. L. Fisher
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration